QQ客服 官方微博 反馈留言

	Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing
	Allix-Beguec, Caroline; Arandjelovic, Irena; Bi, Lijun; Beckert, Patrick; Bonnet, Maryline; Bradley, Phelim; Cabibbe, Andrea M.; Cancino-Munoz, Irving; Caulfield, Mark J.; Chaiprasert, Angkana
刊名	NEW ENGLAND JOURNAL OF MEDICINE
	2018
卷号	379期号:15
ISSN号	0028-4793
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3609610
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Allix-Beguec, Caroline,Arandjelovic, Irena,Bi, Lijun,et al. Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing[J]. NEW ENGLAND JOURNAL OF MEDICINE,2018,379(15).
APA	Allix-Beguec, Caroline.,Arandjelovic, Irena.,Bi, Lijun.,Beckert, Patrick.,Bonnet, Maryline.,...&Zhu, Baoli.(2018).Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing.NEW ENGLAND JOURNAL OF MEDICINE,379(15).
MLA	Allix-Beguec, Caroline,et al."Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing".NEW ENGLAND JOURNAL OF MEDICINE 379.15(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。